The Clinical Biochemistry of Obesity-More Than Skin Deep

Heart Lung and Circulation

Volumn 16, Issue SUPPL. 3, 2007, Pages

  Sikaris, Kenneth Andrew ^a  

^a MELBOURNE PATHOLOGY   (Australia)

Author keywords

Dyslipidaemia; Insulin level; Obesity; Sex hormone binding globulin; SHBG

Indexed keywords

ALANINE AMINOTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ATHEROGENESIS; BIOCHEMISTRY; CLINICAL PRACTICE; CORRELATION ANALYSIS; DEVELOPED COUNTRY; DIET RESTRICTION; DISEASE ASSOCIATION; DYSLIPIDEMIA; FATTY LIVER; HUMAN; HYPERINSULINEMIA; HYPERURICEMIA; IN VIVO STUDY; INSULIN RESISTANCE; KIDNEY INJURY; LABORATORY TEST; LIPID BLOOD LEVEL; METABOLIC SYNDROME X; MICROALBUMINURIA; OBESITY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS;

DYSLIPIDEMIAS; HUMANS; INSULIN; INSULIN RESISTANCE; OBESITY; PROGNOSIS; REFERENCE VALUES; SEX HORMONE-BINDING GLOBULIN; TRIGLYCERIDES;

EID: 34547828961     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2007.05.001     Document Type: Article

References (64)

1. Cameron A.J., Welborn T.A., Zimmet P.Z., Dunstan D.W., Owen N., Salmon J., Dalton M., Jolley D., and Shaw J.E. Overweight and obesity in Australia: The 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med J Aust 178 (2003) 427-432
2. Calle E.E., Thun M.J., Petrelli J.M., Rodriquez C., and Heath Jr. C.W. Body-mass index and mortality in a prospective cohort of U.S. adults. N Eng J Med 341 (1999) 1097-1105
3. Malis C., Rasmussen E.L., Poulsen P., Petersen I., Christensen K., Beck Nielsen H., Astrup A., and Vaaq A.A. Total and regional fat distribution is strongly influenced by genetic factors in young and elderly twins. Obes Res 13 (2005) 2139-2145
4. Swinburn B.A., Jolley D., Kremer P.J., Salbe A.D., and Ravussin E. Estimating the effects of energy imbalance on changes in body weight in children. Am J Clin Nutr 83 (2006) 859-863
5. Ford E.S., Williamson D.F., and Liu S. Weight change and diabetes incidence: findings from a national cohort of U.S. adults. Am J Epidemiol 146 (1997) 214-222
6. Colditz G.A., Willett W.C., Stampfer M.J., Manson J.E., Hennekens C.H., Arky R.A., and Speizer F.E. Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 132 (1990) 501-513
7. Hu F.B., Manson J.E., Stampfer M.J., Colditz G., Liu S., Solomon C.G., and Willet W.C. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med. 345 (2001) 790-797
8. Must A., Spadano J., Coakley E.H., Field A.E., Colditz G., and Dietz W.H. The disease burden associated with overweight and obesity. JAMA 282 (1999) 1523-1529
9. Albu J., and Pi-Sunyer F.X. Obesity and diabetes. In: Bray G.A., Bouchard C., and James W.P.T. (Eds). Handbook of obesity (1998), Marcel Dekker, New York 697-707
10. DeFronzo R.A. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37 (1988) 667-687
11. Borch-Johnson K., Colagiuri S., Balkau B., Glumer C., Carstensen B., Ramachandran A., Dong Y., and Gao W. Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia. Diabetalogia 47 (2004) 1396-1402
12. Braadtvedt G., Gamble G., and Kyle C. Metabolic characteristics of patients with apparently normal fasting plasma glucose. N Z Med J 119 (2006) U2123
13. Wilcox G., Sikaris K.A., Birchall T., and Stringer M. Age and sex related reference intervals for fasting plasma glucose. Clin Biochem Rev 19 (1998) 72
14. Watson N., Sikaris K.A., Morris G., and Mitchell D.K. Confirmation of age-related rise in reference intervals for fasting glucose using the Bhattacharya method and patient data. Clin Biochem Rev 20 (1999) 92
15. Thomas G.N., Jiang C.Q., McGhee S.M., Zhang W.S., Lao X.Q., Schooling M., Adab P., Lam T.H., Cheng K.K., and Guangzhou Biobank Cohort Study Steering Committee. Association of vascular risk factors with increasing glycemia even in normoglycemic subjects in an older Chinese population: the Guangzhou Biobank Cohort Study. Metabolism 55 (2006) 1035-1041
16. Rhee M.K., Zeimer D.C., Kolm P., and Phillips L.S. Postchallenge glucose rises with increasing age even when glucose tolerance is normal. Diabet Med 23 (2006) 1174-1179
17. Orencia A.J., Daviglus M.L., Dyer A.R., Walsh M., Greenland P., and Stamler J. One-hour postload plasma glucose and risks of fatal coronary heart disease and stroke among nondiabetic men and women: the Chicago Heart Association Detection Project in Industry (CHA) Study. J Clin Epidemiol 50 (1997) 1369-1376
18. Meisenger C., Wolke G., Brasche S., Strube G., and Heinrich J. Postload plasma glucose and 30-year mortality among nondiabetic middle-aged men from the general population: the ERFORT Study. Ann Epidemiol 16 (2006) 534-539
19. Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., and Quon M.J. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85 (2000) 2402-2410
20. Yokoyama H., Emoto M., Fujiwara S., Motoyama K., Morioka T., Komatsu M., Tahara H., Koyama H., Shoji T., Inaba M., and Nishiwaza Y. Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment are useful indexes of insulin resistance in type 2 diabetic patients with wide range of fasting plasma glucose. J Clin Endocrinol Metab 89 (2004) 1481-1484
21. Li C., Ford E.S., McGuire L.C., Mokdad A.H., Little R.R., and Raeven G.M. Trends in hyperinsulinemia among nondiabetic adults in the U.S. Diabetes Care 29 (2006) 2396-2402
22. Matsuda M., and DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22 (1999) 1462-1470
23. Leonetti F., Iacobellis G., Zappaterreno A., Ribaudo M.C., Tiberti C., Vecci E., and Di Mario U. Insulin sensitivity assessment in uncomplicated obese women: comparison of indices from fasting and oral glucose load with euglycemic hyperinsulinemic clamp. Nutr Metab Cardiovasc Dis 14 (2004) 366-372
24. Cervenakova Z., Ksinantova L., and Koska J. Effect of body composition on indices of insulin sensitivity and beta-cell function in healthy men. Endocr Regul 36 (2002) 73-77
25. Alberti F.G.M.M., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 5 (1998) 539-553
26. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
27. Despres J.P., and Krauss R.M. Obesity and lipoprotein metabolism. In: Bray G.A., and Bouchard C. (Eds). Handbook of obesity (2003), Marcel Dekker, New York
28. Howard B.V., Ruotolo G., and Robbins D.C. Obesity and dyslipidemia. Endocrinol Metab Clin North Am 32 (2003) 855-867
29. Taskinen M.R. Lipoprotein lipase in diabetes. Diabetes Metab Rev 3 (1987) 551-570
30. Denke M.A., Sempos C.T., and Grundy S.M. Excess body weight. An under-recognized contributor to dyslipidemia in white American women. Arch Intern Med 154 (1994) 401-410
31. Sternfeld B., Sidney S., Jacobs Jr. D.R., Sadler M.C., Haskell W.L., and Schreiner P.J. Seven-year changes in physical fitness, physical activity, and lipid profile in the CARDIA study. Coronary artery risk development in young adults. Ann Epidemiol 9 (1999) 25-33
32. Howard B.V., Bogardus C., Ravussin E., Foley J.E., Lillioja S., Mott D.M., Bennett P.H., and Knowler W.C. Studies of the etiology of obesity in Pima Indians. Am J Clin Nutr 53 Suppl. (1991) 1577S-1585S
33. Williams P.T., and Krauss R.M. Associations of age, adiposity, menopause, and alcohol intake with low-density lipoprotein subclasses. Arterioscler Thromb Vasc Biol 17 (1997) 1082-1090
34. Raeven G.M., Chen Y.D., Jeppesen J., Maheux P., and Krauss R.M. Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J Clin Invest 92 (1993) 141-146
35. O'Neal D., Grieve G., Rae D., Dragicevic G., and Best J.D. Factors influencing Lp[a]- particle size as determined by gradient gel electrophoresis. J Lipid Res 37 (1996) 1655-1663
36. Rizzo M., and Berneis K. Should we measure routinely the LDL peak particle size?. Int J Cardiol 107 (2006) 166-170
37. Rutkowski P., Klassen A., Sebekova K., Bahner U., and Hedland A. Renal disease in obesity: the need for greater attention. J Ren Nutr 16 (2006) 216-223
38. Hoffman I.S., Jimenez E., and Cubeddu L.X. Urinary albumin excretion in lean, overweight and obese glucose tolerant individuals: its relationship with dyslipidaemia, hyperinsulinaemia and blood pressure. J Hum Hypertens 15 (2001) 407-412
39. Vazquez-Mellado J., Garcia C.G., Vazquez S.G., Medrano G., Ornelas M., Alcocer L., Marquez A., and Burgos-Vargas R. Metabolic Syndrome and Ischemic Heart Disease in Gout. J Clin Rheumatol 10 (2004) 105-109
40. Wannamethee S.G., Shaper A.G., and Whincup P.H. Serum urate and the risk of major coronary heart disease events. Heart 78 (1997) 147-153
41. Moriarity J.T., Folsom A.R., Iribarren C., Nieto F.J., and Rosamond W.D. Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol 10 (2000) 136-143
42. Lee D.H., Ha M.H., and Christiani D.C. Body weight, alcohol consumption and liver enzyme activity - a 4-year follow-up study. Int J Epidemiol 30 (2001) 766-770
43. Seppala-Lindroos A., Vehkavaara S., Hakkinen A.M., Goto T., Westerbacka J., Sovijarvi A., Halavaara J., and Yki-Jarvinen H. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum FFA independent of obesity in normal men. J Clin Endocrinol Metab 87 (2002) 3023-3028
44. Kendrick J.S., Wilkinson J., Cartwright I.J., Lawrence S., and Higgins J.A. Regulation of the assembly and secretion of very low density lipoproteins by the liver. Biol Chem 379 (1998) 1033-1040
45. Reid A.E. Nonalcoholic steatohepatitis. Gastroenterology 121 (2001) 710-723
46. Ruhl C.E., and Everhart J.E. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology 124 (2003) 71-79
47. Sargin M., Uygur-Bayramicli O., Sargin H., Orbay E., and Yayla A. Association of nonalcoholic fatty liver disease with insulin resistance: is OGTT indicated in nonalcoholic fatty liver disease?. J Clin Gastroenterol 37 (2003) 399-402
48. Leino A., Impivaara O., Irjala K., Maki J., Peltola O., and Jarvisalo J. Health-based reference intervals for ALAT, ASAT and GT in serum, measured according to the recommendations of the European Committee for Clinical Laboratory Standards (ECCLS). Scand J Clin Lab Invest 55 (1995) 243-250
49. Thulstrup A.M., Norgard B., Steffensen F.H., Vilstrup H., Sorensen H.T., and Lauritzen T. Waist circumference and body mass index as predictors of elevated alanine transaminase in Danes aged 30-50 years. Dan Med Bull 46 (1999) 429-431
50. Dufour D.R., Lott J.A., Nolte F.S., Gretch D.R., Koff R.S., and Seeff L.B. Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests. Clin Chem 46 (2000) 2027-2049
51. Riedner C.E., Rhoden E.L., Ribeiro E.P., and Fuchs S.C. Central obesity is an independent predictor of erectile dysfunction in older men. J Urol 176 (2006) 1519-1523
52. Osuna J.A., Gomez-Perez R., Arata-Bellabarba G., and Villaroel V. Relationship between BMI, total testosterone, sex hormone-binding-globulin, leptin, insulin and insulin resistance in obese men. Arch Androl 52 5 (2006) 355-361
53. Gapstur S.M., Kopp P., Gann P.H., Chiu B.C., Colangelo L.A., and Liu K. Changes in BMI modulate age-associated changes in sex hormone binding globulin and total testosterone, but not bioavailable testosterone in young adult men: the CARDIA Male Hormone Study. Int J Obes (Lond) 31 (2007) 685-691
54. Hassan M.A., and Killick S.R. Ultrasound diagnosis of polycystic ovaries in women who have no symptoms of polycystic ovary syndrome is not associated with subfecundity or subfertility. Fertil Steril 80 (2003) 966-975
55. Mathur R.S., Moody L.O., Landgrebe S.C., Peress M.R., Rust P.F., and Williamson H.O. Sex-hormone-binding globulin in clinically hyperandrogenic women: association of plasma concentrations with body weight. Fertil Steril 38 (1982) 207-211
56. Ducluzeau P.H., Cousin P., Malvoisin E., Bornet H., Vidal H., Laville M., and Pugeat M. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome. J Clin Endocrinol Metab 88 (2003) 3626-3631
57. Bataille V., Perret B., Evans A., Amouyal P., Arveiler D., Ducimetiere P., Bard J.M., and Ferrieres J. Sex hormone-binding globulin is a major determinant of the lipid profile: the PRIME study. Atherosclerosis 179 (2005) 369-373
58. Peiris A.N., Sothmann M.S., Aiman E.J., and Kissebah A.H. The relationship of insulin to sex hormone-binding globulin: role of adiposity. Fertil Steril 52 (1989) 69-72
59. Jayagopal V., Kilpatrick E.S., Jennings P.E., Hepburn D.A., and Atkin S.L. The biological variation of testosterone and sex hormone-binding globulin (SHBG) in polycystic ovarian syndrome: implications for SHBG as a surrogate marker of insulin resistance. J Clin Endocrinol Metab 88 (2003) 1528-1533
60. Haffner S.M., Valdez R.A., Morales P.A., Hazuda H.P., and Stern M.P. Decreased sex hormone-binding globulin predicts noninsulin-dependent diabetes mellitus in women but not in men. J Clin Endocrinol Metab 77 (1993) 56-60
61. Lindstedt G., Lundberg P.A., Lapidus L., Lundgren H., Bengtsson C., and Bjorntorp P. Low sex-hormone-binding globulin concentration as independent risk factor for development of NIDDM. 12-yr follow-up of population study of women in Gothenburg, Sweden. Diabetes 40 (1991) 123-128
62. Ding E.L., Song Y., Malik V.S., and Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes. JAMA 295 (2006) 1288-1299
63. Lapidus L., Lindstedt G., Lundberg P.A., Bengtsson C., and Gredmark T. Concentrations of sex-hormone binding globulin and corticosteroid binding globulin in serum in relation to cardiovascular risk factors and to 12-year incidence of cardiovascular disease and overall mortality in postmenopausal women. Clin Chem 32 (1986) 146-152
64. Kalme T., Seppala M., Qiao Q., Koistinen R., Nissinen A., Harrela M., Loukovarra M., Leinonen P., and Tuomilehto J. Sex hormone-binding globulin and insulin-like growth factor-binding protein-1 as indicators of metabolic syndrome, cardiovascular risk, and mortality in elderly men. J Clin Endocrinol Metab 90 (2005) 1550-1556